Modular Medical Inc

Modular Medical Inc(MODD)股票分析

$3.460

-0.144 (-4.16%)收盤時

Loading chart…
High
3.960
Open
3.960
VWAP
3.55
Vol
521.11K
Mkt Cap
50.76M
Low
3.220
Amount
1.85M
EV/EBITDA, TTM
0.00

Modular Medical, Inc. is a medical device company. The Company is focused on the design, development, and commercialization of insulin pumps using technology to increase pump adoption in the diabetes marketplace. The Company's product seeks to serve both the type 1 and type 2 diabetes markets for those individuals requiring insulin. MODD1, its product, is a high-precision pump. MODD1's features include three parts - one reusable, two disposable - snap together to form the working system; one button interface; 90-day reusable, three-day disposable; removable system, slim profile, lighter weight, and no external controller required, no charging and no battery replacement. Its pump product comprises the pump, a disposable cartridge that holds the insulin reservoir, a baseplate that affixes the pump product to the user's body and the infusion set, which includes a cannula to infuse the insulin into the body.

AI analysis of Modular Medical Inc (MODD)

buy

Modular Medical Inc is a good buy right now due to its recent FDA clearance for a next-generation insulin patch pump, which has the potential to significantly increase market share. The current price is $3.46, and the stock has shown a 20-day change of +44.77%, indicating strong momentum. However, the company has reported consistent losses, with a net income of -7,790,000 USD in Q2 2026, which remains a risk for investors.

估值指標

The current forward P/E ratio for Modular Medical Inc (MODD) is 0.00, compared to its 5-year average forward P/E of -2.62.

Forward P/E

Strongly Overvalued
5Y Average P/E
-2.62
Current P/E
0.00
高估
-1.42
低估
-3.81

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
高估
0.00
低估
0.00

Forward P/S

Fair
5Y Average P/S
169.25
Current P/S
9.20
高估
463.79
低估
-125.29

事件時間軸

2026-08-03 (ET)

08:30:00

Modular Medical Plans to Launch Tubeless Patch Pump in Five U.S. Markets in October 2026

2026-07-23 (ET)

08:30:00

Modular Medical Forms Pivot Innovation Council

2026-07-16 (ET)

08:30:00

Modular Medical Partners with IMO Health to Develop Diabetes Algorithm

2026-07-15 (ET)

08:30:00

Modular Medical Releases Positive Market Study Findings for Pivot Tubeless Patch Pump

2026-07-01 (ET)

08:00:00

Modular Medical Submits Software Enhancements for Pivot System to FDA

資訊

MODD FAQ — answered by Alphio AI

Modular Medical, Inc. is a medical device company. The Company is focused on the design, development, and commercialization of insulin pumps using technology to increase pump adoption in the diabetes marketplace. The Company's product seeks to serve both the type 1 and type 2 diabetes markets for those individuals requiring insulin. MODD1, its product, is a high-precision pump. MODD1's features include three parts - one reusable, two disposable - snap together to form the working system; one button interface; 90-day reusable, three-day disposable; removable system, slim profile, lighter weight, and no external controller required, no charging and no battery replacement. Its pump product comprises the pump, a disposable cartridge that holds the insulin reservoir, a baseplate that affixes the pump product to the user's body and the infusion set, which includes a cannula to infuse the insulin into the body. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

Modular Medical Inc is a good buy right now due to its recent FDA clearance for a next-generation insulin patch pump, which has the potential to significantly increase market share. The current price is $3.46, and the stock has shown a 20-day change of +44.77%, indicating strong momentum. However, the company has reported consistent losses, with a net income of -7,790,000 USD in Q2 2026, which remains a risk for investors.

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

免費開始